Market News AIOpen the app

Maxim Group still thinks Tenon Medical is a good buy but cut its price target from $10 to $5.

OpinionRead the original at moomoo.com
Neutral

The Buy rating favors Tenon Medical's shares, but the lower target points the other way. The report covers an analyst's view, not a change in the company's sales or operations, so it gives no clear new business signal.

TNON · Tenon Medical, Inc.

AI read · Neutral

The AI's read

The rating remains favorable, but the lower target points to a less favorable view of the shares. This is one analyst's opinion, not a report of new sales, products, or company results. It gives no clear new sign about the company's business.

Get alerts for TNON

Follow Tenon Medical, Inc. (TNON) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TNON
Free on the App Store and Google Play, or on the web.